Supplementary MaterialsFigure S1: Expression of ITGAV, effect on viability and proliferation. UM-UC-3 and RT-4 cells were measured using the Alexa Fluor 488 annexin V/Dead Cell LDN-214117 Apoptosis Kit (Invitrogen). In addition, UM-UC-3 luc2 and RT-4 cells were seeded into a 6-well plate and exposed to a concentration series of GLPG0187 (0C500 ng/ml). 48 h after incubation, cells were harvested and processed for annexin V/PI staining. The percentage of viable (AnnexinV?/PI?), LDN-214117 dead (PI+/AnnexinV?), and total apoptotic cells (AnnexinV+) are shown (G). Proliferation rate (mitochondrial activity as assessed with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (optical density at 490 nm)) in the 2 2 v kd clones (respectively closed circles and triangles) and NT (open circles) UM-UC3luc2 (H) and RT-4 (I) cells. The effects of GLPG0187 treatment on proliferation rate of UM-UC-3luc2 (J) and RT-4 cells (K) after 24, 48 and 72 h of treatment was assessed with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (optical density at 490 nm). Data are presented as mean SEM (n?=?3).(TIF) pone.0108464.s001.tif (3.4M) GUID:?53F57C65-DCCF-40B3-A8B2-96376CA78B05 Figure S2: Protein levels of EMT markers. Representative images of flow cytometry plots of relative E-cadherin expression levels in UM-UC-3luc2 (A) and RT-4 (B) cells transduced with an shRNAi construct targeting ITGAV (sh clone1 and 2) or a non-targeting short hairpin (NT). Western Blot analysis of E-cadherin and b-actin in RT-4 cells (C) and Elf1 densitometry analysis of the relative protein expression levels, measured with western blot analysis, compared to respectively NT or vehicle treated cells and corrected for b-actin expression levels (D). Representative images of flow cytometry plots of relative Vimentin expression levels in UM-UC-3luc2 (F) and RT-4 (G) cells transduced with an shRNAi construct targeting ITGAV (sh clone1 and 2) or a non-targeting short hairpin (NT). Representative images of flow cytometry plots of relative N-cadherin expression levels in UM-UC-3luc2 (H) and RT-4 (I) cells transduced with an shRNAi construct targeting ITGAV (sh clone1 and 2) or a non-targeting short hairpin (NT).(TIF) pone.0108464.s002.tif (1.5M) GUID:?E5B705CA-C7EB-4511-8CD7-3A07569BB277 Figure S3: Protein levels of intracellular EMT markers. Densitometry analysis of the relative protein expression levels of SNAI1 (A), SNAI2 (B) and ZEB1 (C), measured with western blot analysis, compared to respectively NT or vehicle treated cells and corrected for b-actin expression amounts in UM-UC-3 cells or RT-4 cells (respectively NT, sh clone 1, control along with a focus series of GLPG0187). Whole audiograms of ZEB1 and ZEB2 western blot analysis, displaying multiple additional bands (D). Representative images of cytometry plots of ZEB2 protein expression in UM-UC-3 NT LDN-214117 and sh clones 1 and 2 (E) and ZEB2 protein expression in RT-4 NT and sh clones 1 and 2 (F). LDN-214117 Representative images of cytometry plots of ZEB2 protein expression in UM-UC-3 cells (G) or RT-4 cells (H) treated with a dose-range of GLPG0187. Real time qPCR analysis of TWIST in UM-UC-3 and RT-4 cells (I). Relative expression levels are shown compared to respectively NT or non-treated cells.(TIF) pone.0108464.s003.tif (1.7M) GUID:?85D89B0B-38CC-449B-A909-B0F5F66E2BFA Physique S4: Immunofluorescence of E-cadherin and Vimentin. Representative confocal images of E-cadherin staining in UM-UC-3 NT (A), ITGAV knockdown clone 1 (B) and UM-UC-3 cells treated with 500 ng/ml GLPG0187 for 24 h (C) Representative confocal images of Vimentin staining in UM-UC-3 NT (D), ITGAV knockdown clone 1 (E) and UM-UC-3 cells treated with 500 ng/ml GLPG0187 for 24 h (F). Representative confocal images of E-cadherin staining in RT-4 NT (G), ITGAV knockdown clone 1 (H) and UM-UC-3 cells treated with 500 ng/ml GLPG0187 for 24 h (I) Representative confocal images of Vimentin staining in RT-4 NT (J), ITGAV knockdown clone 1 (K) and RT-4 cells treated with 500 ng/ml GLPG0187 for 24 h (L).(TIF) pone.0108464.s004.tif (6.8M) GUID:?E143C48D-0058-4F2A-A4C1-6413B12D1D7C Physique S5: Tumor-initiating cell characteristics. LDN-214117 Representative image of a colony in a clonogenic assay of UM-UC-3 cells 14 days after seeding (5x magnification) (A). Schematic representation of the urosphere protocol, adapted from Bisson et al [35]. (B) Representative images of UM-UC-3 NT (C) and ITGAV knockdown (D) P0 urospheres 10 days after seeding. Scale bar represents 50 m (20x magnification).(TIF) pone.0108464.s005.tif (1.4M) GUID:?5144B8CC-6F81-49BD-985B-51B68FAFA1AA Physique S6: Expression levels of markers. Expression levels of ITGAV knockdown clones 1 and 2 were compared to control cells transduced with a.